1,767 results on '"Patil, Vijay"'
Search Results
2. Design and Analysis of Slotted Microstrip Patch Array Antenna at 2.4GHz for WLAN
3. Brønsted acid functionalized melamine-supported porphyrin trimer for one-step synthesis of alkyl-12-hydroxyoctadecanoate under irradiation of LED light
4. Visible-Light Mediated Reaction of Indole with Aryl Halides Using Porphyrin Photocatalyst: A Feasible Technique to Afford N-Functionalized Indoles
5. Modified four-port dual-band (FPDB) scaled rectangular inset-feed MIMO antenna for 5G-millimeter-wave applications including 28.0 GHz/38.0 GHz bands
6. Lorlatinib in the second line and beyond for ALK positive lung cancer: real-world data from resource-constrained settings
7. Diaryl Pyrazoline, 1,3,4-Oxadizole, and 1,2,4-Triazole Pharmacophore Hybridization: Design, Synthesis, HDAC Inhibition, and Caspase 3/7 Activation Studies
8. Investigations into the Poor Energy use Practices of Irrigation Pumps by Indian Farmers: A Case Study
9. Means of Enhancing the Power Output and Widening the Operational Frequency Band of Vibration-Based Electromagnetic Energy Harvester
10. Correction: Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, over the Past 15 Years
11. Quantitative Estimation of Piperine in Ayurvedic Formulations by HPTLC
12. Emergencies
13. CT-Based Screening for Pulmonary Metastases in Head and Neck Squamous Cell Cancers: Diagnostic Accuracy and Cost Comparison with PET-CECT
14. Exploring novel porphyrin photocatalyst for the conversion of frying oil to biodiesel: A step for globular economy
15. Novel porphyrin photocatalyst intertwined with ionic liquid and sulfonic acid groups for facile photo-transesterification of used frying oil
16. Role of Selective Neck Dissection in Clinically Single Node Positive Disease in Oral Cavity Cancers
17. Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, Over the Past 15 Years
18. Uniqueness of lung cancer in Southeast Asia
19. Repurposing pantoprazole in combination with systemic therapy in advanced head and neck squamous cell carcinoma: a phase I/II randomized study
20. Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer
21. RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer
22. Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India
23. Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy
24. Long-Term Update of a Phase 3 Randomized Study Comparing Once-a-Week Versus Once-Every-3-Weeks Cisplatin Along With Radiation in Head and Neck Cancer
25. A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC
26. Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice
27. Melamine-based porphyrin photosensitizer comprising sulphonic acid moieties for efficient aerobic oxidative acetalization of furfuryl alcohol: An access to octane booster under visible light
28. Bayesian Effective Biological Dose Determination in Immunotherapy Response Trial
29. Anaplastic Cancer: Our Experience
30. Experimental investigation of CO2 level in the closed room including the effect of ventilation and use of snake plants
31. Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation – a randomised trial
32. Net energy analysis of sugarcane based ethanol production
33. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity
34. Endophytes: a potential bioagent for plant disease management
35. Electric Vehicle Technology: Trends and Challenges
36. Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer
37. Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained Settings
38. Ionic liquid mediated synthesis of TiO2-ZnO-BMIMBr nanocomposite for electrochemical sensing of neurotransmitter
39. A phase III randomized, open-label study to establish the superiority of triple oral metronomic therapy (OMCT) used in addition to chemotherapy regimen (paclitaxel + carboplatin) over chemotherapy alone for the treatment of advanced unresectable head and neck cancer squamous cell cancer (HNSCC).
40. VAMANA: A phase 2 study of low-dose bevacizumab plus CCNU in relapsed/recurrent glioblastoma.
41. Long term results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.
42. Long term results of phase 3 randomized study evaluating the addition of low dose nivolumab to palliative chemotherapy in head and neck cancer.
43. A randomized trial to assess the effect of oral cryotherapy in the prevention of mucositis in patients with head and neck cancer receiving chemo-radiotherapy.
44. Randomized double-blind placebo-controlled trial evaluating pregabalin for chronic cough in patients with lung cancer.
45. Phase 3 randomized study for evaluation of physician choice Rx versus best supportive care as second-line or beyond therapy in head and neck cancer with poor performance status.
46. Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab
47. Caregiver burden in older Indian patients with cancer- Experience from a tertiary care center
48. Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial
49. Clinical Utility of Liquid Biopsy (Cell-free DNA) Based EGFR Mutation Detection Post treatment Initiation as a Disease Monitoring Tool in Patients With Advanced EGFR-mutant NSCLC
50. G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.